| Literature DB >> 34120504 |
Aleksandra L Lindgren1, Andrea Hui Austin2, Kathleen M Welsh2.
Abstract
The term "COVID arm" has been coined to describe a harmless delayed hypersensitivity reaction occurring approximately a week after administration of the novel SARS-CoV-2 mRNA vaccine. It appears as a red, warm, pruritic, indurated, or swollen area in the vicinity of the vaccine site. These reactions, especially if accompanied by systemic symptoms, have been mistaken for cellulitis. We report 3 cases of COVID arm, 2 of which were mistaken for cellulitis. Distinguishing features of COVID arm from cellulitis include pruritus as a common finding, occurrence approximately a week after vaccination, a lack of progression of symptoms, rapid response to topical steroids, and/or spontaneous resolution usually over 4 to 5 days.Practice Points:• Patients receiving SARS-CoV-2 vaccines may experience delayed hypersensitivity reactions characterized by erythema, swelling, and itching occurring near the vaccination site (COVID arm), approximately a week after vaccination.• Clinicians can distinguish SARS-CoV-2 vaccine reactions from cellulitis by the time of onset (approximately a week vs 5 days), by the lack of progression of symptoms, and resolution over 4 to 5 days.• Severe cases of COVID arm may be treated with topical steroids.Entities:
Keywords: COVID arm; COVID-19 vaccine; T-cell mediated; delayed hypersensitivity reactions; mRNA vaccines; post-vaccination reactions; skin and soft tissue infection; treatment of COVID arm; vaccine allergy; vaccine safety
Mesh:
Substances:
Year: 2021 PMID: 34120504 PMCID: PMC8202256 DOI: 10.1177/21501327211024431
Source DB: PubMed Journal: J Prim Care Community Health ISSN: 2150-1319